Cryosa, Inc.


Cryosa is a clinical stage company dedicated to developing a mask-free, hose-free, and implant-free treatment for moderate to severe Obstructive Sleep Apnea (OSA). Their mission is to provide a better sleep solution that allows everyone to sleep, rest, and live brighter days. Led by an experienced team with deep roots in the medical device industry, Cryosa aims to revolutionize OSA treatment through innovative, minimally invasive technology.

Industries

biotechnology
clinical-trials
health-care
medical-device

Nr. of Employees

small (1-50)

Cryosa, Inc.

Minnesota City, Minnesota, United States, North America


Products

Incisionless controlled cooling therapy for obstructive sleep apnea (in development)

A minimally invasive, incisionless therapy in development that uses controlled cooling to reduce airway tissue and improve airway patency for patients with moderate to severe OSA. Described as non-implant and intended to avoid continuous positive airway pressure (CPAP) interfaces.


Services

Clinical trial enrollment and participation (ARCTIC-3 pilot study)

Enrollment of participants into a U.S. pilot study to assess safety and effectiveness of an investigational incisionless controlled cooling therapy for moderate to severe OSA.

Expertise Areas

  • Clinical trial management
  • Multi-site clinical research
  • Minimally invasive device development
  • Interventional cryotherapy and controlled tissue cooling
  • Show More (4)

Key Technologies

  • Controlled tissue cooling (cryotherapy/cryoablation)
  • Incisionless/minimally invasive interventional devices
  • Airway tissue remodeling techniques
  • Pilot clinical study protocols
  • Show More (1)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.